Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients

BACKGROUND: Preclinical evidence suggests that sustained adrenergic activation can promote ovarian cancer growth and metastasis. We examined the impact of beta-adrenergic blockade on clinical outcome of women with epithelial ovarian, primary peritoneal or fallopian tube cancers (collectively, EOC)....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer
Asıl Yazarlar: Watkins, Jack L., Thaker, Premal H., Nick, Alpa M., Ramondetta, Lois M., Kumar, Sanjeev, Urbauer, Diana L., Matsuo, Koji, Squires, Kathryn, Lutgendorf, Susan K., Ramirez, Pedro T., Sood, Anil K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575637/
https://ncbi.nlm.nih.gov/pubmed/26301456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29392
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller